Evidence map›Paper›PMID 42591465›Full record

ArticleFrontiers in oncology2026

Gastric inflammatory myofibroblastic tumor in adults: a case report and literature review.

Zhenxuan Chen, Kebing Chen, Yuting Gu, Tao Peng

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhenxuan Chen *Department of Hepatobiliary Surgery, The First Affiliated Hospital of Yangtze University, The First People's Hospital of Jingzhou, Jingzhou, China.
Kebing Chen *Department of Pathology, The First Affiliated Hospital of Yangtze University, The First People's Hospital of Jingzhou, Jingzhou, China.
Yuting GuThe First School of Clinical Medicine, Yangtze University, Jingzhou, China.
Tao PengDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Yangtze University, The First People's Hospital of Jingzhou, Jingzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm of intermediate biological potential, with adult cases being particularly uncommon. We report a 64-year-old man with an incidentally detected gastric mass that was preoperatively suspected to be a gastrointestinal stromal tumor (GIST). The relevant literature on adult gastric IMT was also reviewed. Complete surgical resection with negative margins (R0 resection) remains the mainstay of treatment, whereas patients with confirmed ALK rearrangements may benefit from ALK inhibitor therapy. Histopathological confirmation and long-term surveillance are essential because of the potential for recurrence and occasional aggressive behavior.

Indexed as

adultanaplastic lymphoma kinasegastrointestinal stromal tumorinflammatory myofibroblastic tumorstomach neoplasms

Identifiers

PMID42591465
PMCPMC13462045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.